CME financials
CME Group Inc. · end-of-day data as of Oct 16, 2026
CME Group Inc.
$293.87+15.6%
Buy · 18 analystsPT $299.01 +1.7%
CME reported revenue of $1.71B for the quarter ended Jun 30, 2026 (Q2 FY2026), up 0.8% from a year earlier. It posted diluted EPS of $2.88, free cash flow of $924M and a net margin of 61.1%.
Valuation
- P/E24.9x
- P/E vs own+5.4%
- P/E vs sector+75.2%
- FCF yield+4.0%
- Market cap$106B
Quarterly results
Q2 FY2026: Revenue +0.8% year over year, free cash flow 54.1% of revenue, operating margin 64.9%.
RevenueFree cash flow
| Q2 FY2026 | Jun 30, 2026 | $1.71B | 2.88 | $924M | 69.2% | 64.9% | 61.1% |
| Q1 FY2026 | Mar 31, 2026 | $1.88B | 3.18 | $1.24B | 88.1% | 69.7% | 61.4% |
| Q4 FY2025 | Dec 31, 2025 | $1.65B | 3.24 | $1.1B | 85.4% | 61.8% | 70.8% |
| Q3 FY2025 | Sep 30, 2025 | $1.54B | 2.49 | $950M | 84.5% | 63.3% | 59.1% |
| Q2 FY2025 | Jun 30, 2025 | $1.69B | 2.81 | $1.04B | 86.9% | 66.7% | 59.8% |
| Q1 FY2025 | Mar 31, 2025 | $1.64B | 2.62 | $1.1B | 87.4% | 67.5% | 58.2% |
| Q4 FY2024 | Dec 31, 2024 | $1.53B | 2.40 | $992M | 85.5% | 62.1% | 57.3% |
| Q3 FY2024 | Sep 30, 2024 | $1.58B | 2.50 | $973M | 86.2% | 64.6% | 57.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.53B | 2.42 | $759M | 86.6% | 65.3% | 57.6% |
| Q1 FY2024 | Mar 31, 2024 | $1.49B | 2.35 | $873M | 86.2% | 64.5% | 57.5% |
| Q4 FY2023 | Dec 31, 2023 | $1.44B | 2.24 | $1.02B | 85.2% | 60.0% | 56.6% |
| Q3 FY2023 | Sep 30, 2023 | $1.34B | 2.06 | $837M | 84.6% | 61.3% | 56.1% |